Veidlapa Nr. M-3 (8)

Study Course Description

Andrology

Main Study Course Information

Course Code

RSS_015

Branch of Science

Clinical medicine

ECTS

11.00

Target Audience

Medicine

LQF

Level 8

Study Course Implementer

Course Supervisor

Anatolijs Požarskis

Residency Speciality

Speciality

Sexologist, sex pathologist

Supervisor of Medical Speciality

Anatolijs Požarskis

Contacts

About Study Course

Objective

Ensure the development of theoretical knowledge and practical skills in andrology in order to prepare a doctor for certification in the specialty of sexologist, sex pathologist, in accordance with the regulatory documents of the Republic of Latvia.

Learning Outcomes

Knowledge

1.1. Understands the etiology, pathogenesis, pathological physiology and morphology, clinical manifestations of andrological diseases. 2. Understands the organization of work in an outpatient appointment of an andrologist.

Skills

1.1. Performs clinical and instrumental diagnosis of andrological diseases. 2. Means treatment for andrological patients. 3. Fills out the medical documentation.

Competences

1.1. Compile diagnostic algorithms, analyze and differentiate diseases. 2. Understands, evaluates and chooses different treatment methods for andrological diseases. 3. Within the limits of competence, evaluates and draws up a treatment plan for andrological patients. 4. Analyzes the course of treatment and corrects it as necessary. 5. Analyzes treatment and draws conclusions based on the principles of evidence-based medicine.

Assessment

Individual work

Title	% from total grade	Grade
1. Individual work	-	-
1. Independently studies the literature related to the course topics; 2. Independently prepares for seminars; 3. Independently collects data on the anamnesis of the disease, objectively examines the patient, formulates the primary diagnosis, which is discussed with the instructor; 4. Familiarizes with and analyzes medical documentation; 5. Completes medical documentation; 6. Independently executes the instructions of the certified specialist.

Examination

Title	% from total grade	Grade
1. Examination	-	-
Practical works 90% (Performs clinical and instrumental diagnosis and treatment of andrological diseases). Final test: oral test, during which the resident presents a diary with a list of performed manipulations and operations - 10%. Attendance at seminars is mandatory. Absence of 20% of seminars is allowed for a valid reason. Late practical work must be completed.

Study Course Theme Plan

FULL-TIME

Part 1

Seminar

Modality	Location
-	-

Topics

Embryology, anatomy and physiology of the male genitalia

Seminar

Modality	Location
-	-

Topics

Anomalies of male genital development. Hypospadias, epispadias, cryptorchidism, micropenis. Etiology, pathogenesis, treatment.

Seminar

Modality	Location
-	-

Topics

Inflammatory diseases of male genital organs: prostatitis, orchitis, epididymitis, urethritis. Sexual disorders caused by inflammatory diseases of the male genital organs. Etiology, pathogenesis, treatment. Varicocele. Hydrocele. Etiology, pathogenesis, treatment.

Seminar

Modality	Location
-	-

Topics

Diseases of the vas deferens: infections of the vas deferens, obstruction of the vas deferens. Cystic fibrosis. Congenital aplasia of the vas deferens. Prevalence, pathogenesis, diagnosis, differential diagnosis, treatment. Ejaculation disorders: anejaculation, retrograde ejaculation, premature ejaculation (primary, secondary). Prevalence, pathogenesis, diagnosis, differential diagnosis, treatment.

Seminar

Modality	Location
-	-

Topics

Male infertility. Etiology. Diagnostics. Treatment options. IVF, ICSI manipulations.

Seminar

Modality	Location
-	-

Topics

Male hypogonadism. Hypogonadotropic hypogonadism. Hypergonadotropic hypogonadism. Genetic diseases causing hypogonadism: Klinefelter's syndrome, Turner's syndrome. Late-onset hypogonadism. Sexual disorders caused by hypogonadism. Diagnostics, treatment.

Total ECTS (Creditpoints):

11.00

Number of Residency Seminars:

Length (weeks):

Final Examination:

Residency exam (Theory and practice)

Bibliography

Required Reading

Alexander, N. J. et al. 1995. Handbook of Andrology.

Jockenhovel, F. 2004. Male hypogonadism. Bremen: Germany International Medical Publishers.

Reisman, Y., Porst, H., Lowenstein, L. et al. 2015. The ESSM Manual of Sexual Medicine. Amsterdam: Medix.

Additional Reading

Burnett, A. L. et al. Erectile Dysfunction: AUA Guideline. 2018, American Urological Association Education and Research, Inc, 2018.Carruthers, M. Androgen Deficiency in the Adult Male. Taylor & Francis, London, 2001.

Curruthers, M. 2001. Androgen Deficiency in the Adult Male. London: Taylor&Francis

Erenpreiss, J., Fodina, V., Pozarska, R., Zubkova, K., Dudorova, A. un Pozarskis, A. 2019. Prevalence of testosterone deficiency among aging men with and without morbidities. Aging Male. Jun 1,1-5. doi: 10.1080/13685538.2019.1621832.

Feldman, I. R. et al. 2002. Age trends in the level of serum testosterone and other hormones in middle aged men: longitudinal results from the Massachusetts Male aging study. J Clin Endocrinol Metab. 87‒92.

Hatzimouratidis, K., Amar, E., Eardley, I. et al. 2010. European Association of Urology. Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. Eur Urol. 57(5), 804-814.

Lunenfeld, B. 2002. Textbook of Men’s Health. Midsomer Norton, UK: The Parthenon Publishing Group.

Lunenfeld, B., Mskhalaya, G., Zitzmann, M. et al. 2015. Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men. The Aging Male. 2, 1-11.

McBride, J. A., Culley, C. C. and Coward, R. M. 2015. Diagnosis and management of testosterone deficiency. Asian Journal of Andrology. 17, 177-186.

Michaud, J. E., Billups K. L. and Partin A.W. 2015. Testosterone and prostate cancer: an evidence-based review of pathogenesis and oncologic risk. The Adv Urol. 7(6), 378-387.

10.

Morales, A., Buvat, J., Gooren, L.J., Guay, A.T., Kaufman, J.‐M., Tan, H.M. and Torres, L.O. 2004. Endocrine Aspects of Sexual Dysfunction in Men. The Journal of Sexual Medicine. 1, 69-81. doi:10.1111/j.1743-6109.2004.10111.x

11.

Plaut, S. M., Graziottin, A. and Heaton, J., PW. 2004. Sexual Dysfunction. Abingdon: Health Press Limited.

12.

Požarskis, A. and Ērenpreiss, J. 2010. Late – onset hypogonadism: review of the problem. Procceedings of the Latvian Academy of Sciences. Section B. 64(3/4), 93-97.

13.

Požarskis, A. and Lejnieks, A. 2019. Detection of Late – onset hypogonadism in Men with chronic internal diseases. Proceedings of the Latvian Academy of Sciences. Section B. 73(1(718)), 24-33.

14.

Tajar, A., Huhtaniemi, I. T., O'Neill, T. W. et al. 2012. Characteristics of androgen deficiency in late-onset hypogonadism: results from the European Male Aging Study (EMAS). J Clin Endocrinol Metab. 97(5), 1508-1516.

15.

Vigen, R., O'Donnell, C. I., Baron, A. E. et. al. 2013. Association of testosterone therapy with mortality, myocardial infarction and stroke in men with low testosterone levels. JAMA. 310(17), 1829-1836.

Other Information Sources

ClinicalKey. Available from: https://www.clinicalkey.com

EBSCOhost. Available from: http://search.ebscohost.com/

Medscape. Available from: http://emedicine.medscape.com/

Uptodate. Available from: http://www.uptodate.com/